Clene hosts ALS program update call; no specific data disclosed in filing

Clene Inc.

Company held conference call on December 3, 2025, regarding CNM-Au8 ALS program.
Presentation furnished as Exhibit 99.1 but not textually included in filing.
No financial results, clinical data, or regulatory milestones reported in the 8-K.
Event type is Regulation FD disclosure; no new materially quantifiable information.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.